Myasthenia gravis onset during rheumatic disease: a new paradoxical effect of anti‐TNF alpha therapy?

E-ISSN： 1756-185x|18|3|375-376

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.3, 2015-03, pp. : 375-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 880-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pattern of demyelination occurring during anti-TNF- therapy: a French national survey

By Seror Raphale

British Journal of Rheumatology , Vol. 52, Iss. 5, 2013-05 ,pp. : 868-874

Oxford University Press

Access to resources Recommend Favorite

Oral corticosteroid therapy and present disease status in myasthenia gravis

MUSCLE AND NERVE, Vol. 51, Iss. 5, 2015-05 ,pp. : 692-696

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 12, 2015-12 ,pp. : 1266-1273

John Wiley & Sons Inc

Access to resources Recommend Favorite